Hospira Recalls IV Solution Following Hair Scare

Law360, New York (September 4, 2013, 6:10 PM EDT) -- Hospira Inc. on Friday recalled an amino acid intravenous solution used as a nutritional treatment after a patient found human hair in the product, which could cause inflammation or an allergic response, according to the company.

The company issued a voluntary recall for one lot of its Aminosyn II injection, which is used to supply patients who cannot consume food with nitrogen. A customer found a foreign particle in contact with the product and Hospira confirmed it was hair, it said.

There have been no injuries...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.